ResearcherUniversity of Chieti-PescaraActive in the last 2 years

Michele Fiordaliso

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5284-9220; OpenAlex author ID A5050918912. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Biliary stents can modify the microbiota and promote the progression of pancreatic cancer. Co-author DOI 10.3389/fonc.2026.1633611 ↗
The human microbiota: a double-edged sword against the 'Sword of Damocles' in PDAC diagnosis and therapy. Co-author DOI 10.3389/fonc.2025.1519277 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gabriella Mincione · 2 shared papers, 2025–2026 · strength 0.58
- Paper Biliary stents can modify the microbiota and promote the progression of pancreatic cancer. DOI 10.3389/fonc.2026.1633611 ↗
- Paper The human microbiota: a double-edged sword against the 'Sword of Damocles' in PDAC diagnosis and therapy. DOI 10.3389/fonc.2025.1519277 ↗
Leonardo Mercanti · 1 shared paper, 2025 · strength 0.27
- Paper The human microbiota: a double-edged sword against the 'Sword of Damocles' in PDAC diagnosis and therapy. DOI 10.3389/fonc.2025.1519277 ↗
Maria Sindaco · 1 shared paper, 2025 · strength 0.27
- Paper The human microbiota: a double-edged sword against the 'Sword of Damocles' in PDAC diagnosis and therapy. DOI 10.3389/fonc.2025.1519277 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.